Milton H. Werner Inhibikase Therapeutics, Inc. (IKT) insider trading activity

Milton H. Werner is President and CEO of Inhibikase Therapeutics, Inc.. Currently has a direct ownership of 5.34 Million shares of IKT, which is worth approximately $6.19 Million. The most recent transaction as insider was on Aug 16, 2022, when has been sold 5,000 shares (Common Stock) at a price of $0.8 per share, resulting in proceeds of $4,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.34M

0% 3M change

0% 12M change

Total Value Held $6.19 Million

Milton H. Werner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2022	BUY Open market or private purchase	$4,000 $0.8 p/Share	5,000 Added 0.09%	5,335,433 Common Stock
May 27 2022	BUY Open market or private purchase	$4,900 $0.98 p/Share	5,000 Added 0.09%	5,330,433 Common Stock
May 20 2022	BUY Open market or private purchase	$6,000 $0.6 p/Share	10,000 Added 0.19%	5,325,433 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$44,143 $2.02 p/Share	21,853 Added 0.41%	5,315,433 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$44,143 $2.02 p/Share	21,853 Added 0.41%	5,293,580 Common Stock
May 14 2021	SELL Payment of exercise price or tax liability	$77,654 $4.59 p/Share	16,918 Reduced 0.32%	5,271,727 Common Stock
May 14 2021	BUY Exercise of conversion of derivative security	$16,609 $0.38 p/Share	43,707 Added 0.82%	5,288,645 Common Stock

MHW

Milton H. Werner

President and CEO

Atlanta, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IKT shares.

Notify only if

Value

Insider Trading

Get notified when an Inhibikase Therapeutics, Inc. insider buys or sells IKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Inhibikase Therapeutics, Inc.

Track Activities on IKT

Account